Fundraising FoxFall Line Capital — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Arzeda designs proteins and metabolic pathways using computational tools, including its Archytas protein design software and Scylax metabolic pathway design software.
AI & Machine LearningBiotechDeep TechFoodTechNew MaterialsSeattle, US
Alexandre Zanghellini(Co-Founder & Chief Executive Officer)inEric Althoff(Executive Officer, Director, Promoter)inDavid Baker(Co-founder and Scientific Advisor)Bill Baum(Director)inAndrew Ban(Executive Officer)Daniela Grabs(Executive Officer)
Co-investorsCirculate CapitalSofinnova PartnersSustainable Conversion VenturesContinental Grain CompanyLewis & Clark AgriFoodOS Fund+2 more
Chunk Foods makes plant-based meat alternatives produced through fermentation, including a whole-cut product designed for slicing, slow-cooking, marinating, and roasting.
BiotechConsumerFoodTechNew Materials
Amos Golan(Founder)inAmir Gueron(CFO)inItay Uri(VP R&D)inAlex Malamud(VP Business, US)Michal Gayer(Director of Operations)inJoe Loria(Director of Marketing)in
Co-investorsCheyenne VenturesFLORA VenturesKey1 CapitalStray Dog CapitalThe E14 FundFootPrint Coalition+1 more
Uncaged Innovations is a biomaterials company that makes grain- and plant-based leather alternatives using its proprietary BioFuze platform, which replicates the collagen structure of animal leather.
Advanced ManufacturingBiotechCircular EconomyNew MaterialsWhite Plains, US
Stephanie Downs(Chief Executive Officer)in
Co-investorsAlwyn CapitalGreen Circle Foodtech VenturesPonderosa VenturesStray Dog CapitalGolden SeedsInMotion Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.